Medicine
Ibrutinib
Waldenstrom macroglobulinemia
Rituximab
Internal medicine
Oncology
CXCR4
Macroglobulinemia
Hyperviscosity syndrome
Progression-free survival
Lymphoma
Overall survival
Chronic lymphocytic leukemia
Leukemia
Multiple myeloma
Chemokine
Receptor